Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.75 |
| ▸ | NPC1 | O15118 | 2/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | ANPEP | P15144 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | CASR | P41180 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2943082 | 0.87 | ALDH1A1 (0.73) | ALDH1A1NPC1RAB9AKMT2AHTT | |
| SCHEMBL9424898 | 0.83 | ALDH1A1 (0.73) | ALDH1A1NPC1RAB9AKMT2AHTT | |
| SCHEMBL13212299 | 0.83 | TSHR (0.52) | ALDH1A1KMT2ATSHR | |
| SCHEMBL27802239 | 0.82 | ALDH1A1 (0.59) | ALDH1A1NPC1RAB9AKMT2AHTT | |
| SCHEMBL2910972 | 0.81 | RIPK1 (0.56) | ALDH1A1NPC1RAB9AKMT2AANPEP | |
| SCHEMBL2910863 | 0.81 | SLC1A2 (0.59) | ALDH1A1TSHR | |
| SCHEMBL21435278 | 0.80 | ALDH1A1 (0.68) | ALDH1A1NPC1RAB9AKMT2AHTT | |
| SCHEMBL9425263 | 0.80 | ALDH1A1 (0.68) | ALDH1A1NPC1RAB9AKMT2AHTT | |
| SCHEMBL21004152 | 0.79 | TSHR (0.80) | ALDH1A1NPC1RAB9AKMT2AHTT | |
| SCHEMBL12863555 | 0.79 | ANPEP (0.56) | ALDH1A1KMT2AANPEPTSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1586552-B1 | PROCESS FOR PRODUCING BENZYLAMINE DERIVATIVE | IHARA CHEMICAL IND CO (JP) | 2010-08-25 | — | — | EP | disclosed |
| US-7326813-B2 | Process for producing benzylamine derivative | IHARA CHEMICAL INDUSTRY (JP) | 2008-02-05 | — | — | US | disclosed |
| US-20060155141-A1 | Process for producing benzylamine derivative | ITO AKINORI | 2006-07-13 | — | — | US | disclosed |
| EP-1586552-A1 | PROCESS FOR PRODUCING BENZYLAMINE DERIVATIVE | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2005-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060155141-A1 | Process for producing benzylamine derivative | BRD7, BRD1, BRD2 | ALDH1A1 2660/4885NPC1 3303/4885RAB9A 730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.